Last reviewed · How we verify
NCT03823859: MATcH
Metabolomics of Thyroid Hormones
trial testing Indirect calorimetry in Central Hypothyroidism in 332 participants. Completed in 31 December 2021.
28 July 2021
Quick facts
| Lead sponsor | University Hospital, Basel, Switzerland |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 332 |
| Start date | 12 December 2018 |
| Primary completion | 28 July 2021 |
| Estimated completion | 31 December 2021 |
| Sites | 1 location across Switzerland |
Drugs / interventions tested
- Indirect calorimetry
- Dual energy X-ray Absorptiometry (DXA)
- Blood sampling — full drug profile →
Conditions studied
- Central Hypothyroidism — all drugs for Central Hypothyroidism →
- Hypothyroidism — all drugs for Hypothyroidism →
- Hyperthyroidism — all drugs for Hyperthyroidism →
Sponsor
University Hospital, Basel, Switzerland
Who can join
Adults 18 to 80, any sex, with Central Hypothyroidism or Hypothyroidism. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to develop a metabolome signature of thyroid hormone status. The metabolome signature could be useful in diagnosis and treatment of thyroid dysfunction diseases, especially in cases where TSH cannot be reliably used.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03823859
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Indirect calorimetry
Trials testing the same drug.
- NCT05531305 — Longitudinal Changes in Muscle Mass After Intensive Care · NA · completed
- NCT05553184 — Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10) · NA · completed
- NCT05124860 — A Longitudinal Investigation of Energy Expenditure and Substrate Utilization in Critically Ill Patients · completed
- NCT04474587 — Resting Energy Expenditure in Patients With OHS Treated With Long-term NIV · suspended
- NCT03043469 — Dysfunctional Breathing: Characterisation and Assessment · unknown
Other University Hospital, Basel, Switzerland trials
Trials by the same sponsor.
- NCT07444788 — Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants · Phase 1 · recruiting
- NCT07494214 — Acute Analgesic Effects of MDMA on Experimentally Induced Acute Pain, Hyperalgesia and Allodynia in Healthy Participants · Phase 1 · recruiting
- NCT07419048 — Artificial Intelligence or Human Hand? Evaluating Inferior Vena Cava Imaging for Hydration Status · recruiting
- NCT06978777 — Effect of Caffeine on Cold-stimulated Brown Adipose Tissue Activity · NA · recruiting
- NCT07273630 — Effect of Protein Supplementation and Fluid Restriction on Plasma Sodium Levels in Patients Undergoing Pituitary Surgery · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03823859 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Basel, Switzerland
- Last refreshed: 17 May 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03823859.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing